Objective: To study the outcomes of broncho AE angioplastic sleeve lobectomy (SL) versus pneumonectomy (PN), and the PN:SL ratio after an aggressive policy of parenchyma-sparing surgery to improve postoperative complications rate and long-term quality of life (QoL). Methods: A prospective study was conducted in 490 patients with non-small cell lung cancer between 2005 and 2009. All patients not suitable for standard lobectomy were scheduled for SL, if possible, or for PN; eight patients with functional impairment were directly scheduled for SL. Results: Of 76 procedures, 21 (4%) were PN and 55 (11%) SL (29 bronchoplastic, seven bronchovascular, seven angioplastic; 11 extended to more than one lobe). There were no surgical, oncological or physiological preoperative differences between the groups. The 5-year PN:SL ratio was 1:2.6 (2005: 1:2.1; 2006: 1:2.6; 2007: 1:3.6; 2008: 1:3; 2009: 1:3.5). SL and PN mortality were 2 (3.6%) and 1 (5%), respectively. Postoperative complications occurred in 18 (32%) SL and 7 (33%) PN patients. pN1 ( p = 0.04), vascular reconstruction and upper-left SL were risk factors for postoperative complications of SL ( p = 0.03) but were not detected as a mortality risk. Overall 5-year survival was 61% for SL and 31% for PN. Survival at 5 years was significantly higher for SL ( p = 0.03, Kaplan-Meier). Age <70 years and SL were positive factors for long-term survival. In multivariate modelling, both remained positive factors. Surviving PN patients experienced significantly greater loss of respiratory function and lower QoL than those who avoided this surgery (preoperative score, PN vs SL: 52 vs 51; 3 months, 41 vs 43; and 6 months, 42 vs 51, p = 0.04). The adjuvant treatment complement was higher in SL at 34 (62%) than at PN 10 (47%). The side effects of this treatment were more frequent in patients with more extirpated parenchyma ( p = 0.04). Conclusions: Parenchyma-sparing procedures can reduce the PN rate to less than 10%. A PN:SL index lower than 1:1.5 as a quality standard in a specialised thoracic unit should encourage the use of broncho-angioplastic procedures and improve patient outcomes. Long-term survival, QoL, postoperative lung function test and tolerance of adjuvant therapies are significantly better after SL than PN intervention. #
Introduction
The postoperative mortality of lung cancer depends directly on the number of pneumonectomies (PNs) performed. After PN, mortalities of 9-17% have been reported in several studies [1] [2] [3] . Sleeve lobectomy (SL) has been developed in recent decades to improve patient outcome and to decrease the number of PNs. These techniques, based on bronchial and pulmonary artery reconstruction, produce similar oncological results with significantly lower mortality and less reduction of respiratory function [4] [5] [6] [7] . Initially, these bronchoplastic procedures were suitable for respiratory impairment, whereas N1 disease patients and nonchronic obstructive pulmonary disease (COPD) patients were considered for PN [4] . Nowadays, SL is the procedure of choice for anatomically suited non-small cell lung cancer patients (NSCLC) in all cases, unless oncological results would be compromised [6, 8, 9] .
Long-term results are at least similar in local recurrence and survival [4, 10] , although it has been reported that the preservation of lung parenchyma contributes to improved postoperative respiratory function and decreases the longterm loss of respiratory capacity [11, 12] .
Despite these advantages, SL is a more demanding technique and experience plays an important role in its success at avoiding PN and life-threatening complications. In the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S), PNs performed were 31% and bronchoplastic procedures 2.3% in a series of 2994 patients [1] .
Since September 2005, we have implemented an aggressive policy of parenchyma-sparing surgery for NSCLC patients in our unit. This prospective study had two aims: to determine the ratio of broncho AE angioplastic SL to PN that resulted, and to audit our NSCLC treatment using bronchial, bronchial plus arterial or arterial sleeve resection to analyse postoperative results, loco-regional recurrence and actuarial survival.
Methods
Between September 2005 and December 2009, 490 patients were surgically treated for NSCLC in our unit. Patients with main bronchi or vascular involvement, potentially not resectable by standard lobectomy, were included prospectively in this study. To focus on pulmonary sparing, we included only circumferential resection and endto-end anastomosis (bronchial, bronchial plus pulmonary artery or pulmonary artery sleeve), excluding from analysis partial bronchial or pulmonary artery reconstructions, as well as carinal resection not associated with parenchyma-sparing. This aggressive policy of parenchyma sparing and PN avoidance consisted of performing SL as a first option in all cases when local oncological resections were completed, the amount of spared lung parenchyma was sufficient to fill the thoracic cavity and the circular bronchial anastomoses had appropriate tension. The intra-operative field detection of pN1, tumour extension to other lobe or any other patient characteristics (e.g., lung function test and age) did not preclude SL in any case. Vascular prosthesis or cryopreserved allograft was used for pulmonary artery reconstruction, if needed, for sparing lung parenchyma in this aggressive policy of PN avoidance.
All cases meeting the oncological and functional criteria of the hospital lung cancer guidelines were assessed carefully in a multidisciplinary meeting. Informed consent was obtained in all included cases and the hospital ethics committee approved the lung cancer guideline of this tertiary centre. All NSCLC patients, who were potential candidates for thoracic surgery, had a dedicated chest computerised tomography (CT) scan and an (18F)-fluoro-Dglucose ( 18 FDG) positron emission tomography (PET)/CTscan. ESTS guidelines for mediastinal surgical staging were followed to establish that after the CT and 18 FDG-PET-CT were negative for mediastinal disease, thoracotomy with anatomical pulmonary resection plus systematic mediastinal dissection was carried out by a consultant thoracic surgeon. Clinical staging was performed according to the revised (1997) TNM system and later revised following the International Association for the Study of Lung Cancer (IASLC) guidelines proposed in 2009 [13] . Nodal stations were identified according to the 2009 IASLC mediastinal mapping system. Nonetheless, when direct mediastinal invasion, cN2 or cN1 disease or poor-risk patients were suspected despite the negative clinical staging, a careful invasive mediastinal staging was conducted by the most appropriate method available. Potentially resectable cases with mediastinal nodal involvement underwent preoperative neo-adjuvant chemoradiation therapy treatment and were later reassessed by CT scan and PET-CT scan.
Surgical technique
Before the thoracotomy, all patients underwent a bronchoscopy in the theatre by the operating surgeons. Standard surgical technique was used for lobectomy until the bronchus and pulmonary artery were exposed. At this point, the surgeon made a final decision on the oncological and technical feasibility of sleeve resection versus PN. Circumferential bronchial or pulmonary artery resection, or both, was performed with the best oncological margins possible using a scalpel. Bronchi manipulation was very gentle to protect the blood supply, preserve the bronchial arteries and avoid electrocautery on the surrounding tissues. Frozen sections of the resected margins were examined to ensure complete resection (R0). R2 and R1 were considered unacceptable, and PN was completed to achieve R0, if possible. Bronchial anastomosis was performed employing a continuous running 4/0 polydioxanone suture (PDS, Ethicon Inc., Somerville, NJ, USA) from the cartilaginous-membranous juncture from the mediastinal face of the bronchus to the middle of the cartilaginous ring. The remaining cartilaginous and membranous walls were anastomosed using interrupted 4/0 PDS suture, tied at completion of the end-toend anastomosis [7] . All the knots were tied outside the bronchus. Telescopic sutures were avoided and large-calibre discrepancies were compensated for by placing and tying the sutures properly. Torsion of the bronchial axis can be prevented by careful technique [6] . Suture lines were checked for air leaks with an airway pressure of 30 mm Hg. Concomitant wedge or sleeve resection of the pulmonary artery was performed when necessary, using 5/0 Prolene (Ethicon Inc., Somerville, NJ, USA) under systemic (3000-5000 u, heparin) and local heparinisation. Suture covering was not routinely used. At the end of the procedure, anastomosis was assessed by bronchoscopy and secretions cleared from the airways. Neither inhaled antibiotics nor corticoids were administered as a prophylactic therapy to enhance healing or prevent oedema.
Incision of the inferior pulmonary ligament was routinely performed to minimise tension on the anastomosis. Pericardial incision around spared pulmonary veins was also performed, if necessary.
Postoperative care
Epidural thoracic catheters were inserted in all patients, unless preoperative conditions precluded this procedure. After extubation in theatre, patients enrolled in this study spent the first 12-24 h in the intensive care unit (ICU), where chest drainage and air leak were reviewed hourly. The importance of physiotherapy had been emphasised to the patients preoperatively and these exercises began in the ICU. Fibre-optic bronchoscopy was performed routinely before and at 1 month and 3 months after hospital discharge, and whenever atelectasis or a persistent air leak indicated a need to look for anastomotic complications. Bronchoscopic anastomotic findings were classified as shown in Table 1 . Operative mortality was defined as death directly related to the surgical procedure or within 30 days of the operation.
The site of recurrence was classified as anastomotic, within the ipsilateral thorax, mediastinal or distant. The cause of death was classified as local recurrence, distant metastasis, second primary lung cancer, other cause or unknown. Survival was calculated, and adverse events including all-cause death were evaluated.
Lung function test, arterial gasometry and plethysmography were routinely performed preoperatively and 6 months after surgery in each patient, to compare the forced vital capacity (FVC), forced expiratory volume in the first second (FEV 1 ) and FEV 1 /FVC ratio, measured and expressed as a percentage of reference values from the general population.
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) was administered preoperatively and at 6 and 12 months after surgery. This self-rating questionnaire is composed of 30 questions and incorporates nine multi-item scales: five functional scales (physical, role, cognitive, emotional and social), three symptom scales (fatigue, pain and nausea/ vomiting), a global health/quality of life (QoL) scale and several single items assessing additional symptoms (dyspnoea, sleep disturbance, constipation and diarrhoea). A final item evaluates the perceived economic consequences of the disease.
Statistical analyses were carried out with SPSS v.11 (SPSS Inc., Chicago, IL, USA). Qualitative variables were compared with the x 2 statistical test or Fisher's exact test as appropriate, with a significance level accepted when p < 0.05. The Wilcoxon-signed rank test was used to compare values obtained from the EORTC QLQ-C30 questionnaires before and after surgery. Student's t-test was used to compare parametric data between groups and the MannWhitney U test for nonparametric data. Univariate analysis of all variables was performed first, with the objective of identifying significant factors for inclusion in a multivariate Cox regression model. Multivariate analyses of independent prognostic factors were assessed by Cox proportional hazards. Results are presented as the estimated relative risk with corresponding 95% confidence intervals. KaplanMeier curves were plotted and compared using the log-rank test for univariate analysis.
Results
Of 490 patients included, 92 (19%) suffered from a central NSCLC. Of these, 55 (60%) patients underwent SL and 21 (23%) underwent PN because they were not resectable by standard lobectomy due to main stem bronchus or vascular involvement by either the primary tumour or hilar lymphadenopathy. Patient's characteristics are depicted in Table 2 .
In the SL group, the most frequent technique was circular bronchial reconstruction (40; 72%), alone or associated with vascular reconstruction, followed by angioplastic reconstruction (15; 27%), broncho + angioplasty (10; 18%) and vascular alone (5; 9%). Regarding the location of the tumour, the rightupper SL (RUSL) (28; 51%) was the most frequent, followed by upper-left SL (16; 29%), median SL (4; 7%), right-lower SL (2; 3%) and left-lower SL 5 (9%) (Fig. 1) . The pN1 vascular or bronchial invasion led to SL in only seven (12%) cases, and vascular reconstruction was needed in only three of these cases.
Eight (14%) patients were scheduled only for SL with no chance for PN due to functional impairment; SL surgery was performed in all cases. In 13 (17%) cases, 11 SL and two PN, preoperative chemoradiotherapy was performed, always after N2 was histologically confirmed by an appropriate method.
In total, 11 patients underwent an atypical extended SL. The most frequent procedure was the RUSL plus median lobe (four cases) and the RUSL plus the 6 segment (four cases). These patients did not show significantly more complications than the standard SL ( p > 0.05).
R0 was achieved in all cases. Seven patients needed an extra cut after the first anastomosis due to R1 in the frozen [ ( ) T D $ F I G ] section, and SL was performed eventually. In two patients, the frozen section of the proximal bronchial borders was reported as affected microscopically (R1) and complete PN was required due to excessive tension on the anastomosis and limited sparing of lung parenchyma. Postoperative major or minor complications occurred in 18 (32%) SL and 7 (33%) PN patients (Table 3) . SL and PN mortality was 2 (3%) and 1 (5%), respectively. PN patients experienced significantly more bronchial fistula, atrial fibrillation, empyema and re-operation than the SL group (Table 3) .
In our experience, the most frequent minor complication after circular bronchial anastomosis was sputum retention in 12 (21%) cases. This complication was not significantly related to poor lung function test results ( p > 0.05).
Anastomotic complications occurred in one SL patient (Table 1) . No bronchoscopic stenosis was detected during the surveillance period, although, in five cases, a partial fibrin over the anastomosis was detected and these patients were followed closely. In addition, one patient showed an inflammatory and vascular thrombosis by bronchoscopy, without clinical and chest thoracic scan confirmation. These findings were resolved ad integrum without treatment. No endoscopic treatment was needed in any SL during the follow-up.
The coverage of the anastomosis was performed in 23 (41%) cases without any significant difference in anastomotic complications ( p > 0.05). For SL patients, pN1 ( p = 0.04), vascular reconstruction and upper-left SL ( p = 0.03) were risk factors for postoperative complications, but not for mortality. No other variable (e.g., preoperative chemoradiotherapy, low FEV [1] and histology) was significantly related to increased complications or mortality ( p > 0.05).
The PN:SL ratio depicted in Table 4 was sustained above 1:2 throughout the study period, with a rate of PNs between 2% and 6%.
The patients eligible for postoperative adjuvant therapy were 16 (76%) PN and 34 (62%) SL. Complementary postoperative chemoradiotherapy or chemotherapy alone was started in 14 PN and 34 SL cases. The treatment complement was higher in SL at 34 (62%) versus PN at 10 (47%). The side effects of this treatment were more frequent in patients with more extirpated parenchyma ( p = 0.04).
The global QoL was negatively impacted ( p = 0.04) by PN (preoperative score, PN vs SL: 52 vs 51; 3 months, 41 vs 43; and 6 months, 42 vs 51). However, recovery to baseline did not differ between groups. No other roles (physical function, cognitive function, shoulder function and symptoms) showed any differences between the groups studied. Systemic recurrence was observed in 10 (47%) cases in the PN group (seven bone metastases, six brain metastases and one hepatic case) and 16 (29%) cases in the SL group (eight bone metastases, five brain metastases, three hepatic cases and one adrenal case). The PN group had two cases of local recurrence and the SL group had one mediastinal recurrence. Both local and systemic recurrences were found in five PN cases and one SL case.
The loss of pulmonary function at 6 months was significantly higher in PN than in SL (Table 3 ). In fact, in 12 (21%) patients, FEV 1 improved slightly after surgery, likely related to the absence of the shunt effect.
Survival is depicted in Fig. 2 . SL and PN survival rates (means (months)), 95% confidence interval (CI)) were 46 (40-51) and 34 (26-41) ( p = 0.03). Disease-free survival (DFS, means (months)) was 44 (38-49) and 30 (23-37) ( p = 0.04). Univariate and multivariate Cox analyses are shown in Table  5 . Univariate statistical analysis of the data with a Cox model showed a significant result in favour of sleeve lobectomy and age < 70 years. Multivariate analysis showed a statistically Sleeve pneumonectomies and carinal resection were excluded from this study due to the low number and the morbidity associated with these procedures.
significant positive effect on long-term survival in patients < 70 years old and in SL group.
Comment
Surgical treatment of central NSCLC often leads to PN, jeopardising the long-term QoL and worsening postoperative mortality. SL has been well established as a possible alternative to PN in patients with or without impaired functionality [4, 10, 14] . Our aggressive policy during the period of this study increased the number of bronchoangioplastic procedures, sparing pulmonary parenchyma and dramatically decreasing the number of PNs [9] . Among the principal reasons to choose SL are lower mortality and morbidity, better QoL and survival, and less functional impairment after these operations [4, 7] .
These reconstruction procedures are more technically challenging because a successful anastomosis requires adherence to precise technical principles [6, 7, 15, 16] . These principles include careful intra-operative case selection depending on the anastomosis tension, the amount of spared lung parenchyma and the completeness of local oncological resections. If any of these elements do not meet SL criteria, PN emerges as the most rational choice. In our experience, postoperative problems appeared when the anastomostic tension was abnormally increased or when a small spared pulmonary parenchyma has to occupy the entire chest cavity. Other issues, such as tumour size, pStage, previous chemoradiotherapy treatment [17] or bronchial coverage of the anastomotic, did not show any damaging or preventing role in anastomotic healing.
RUSL is the most frequent type of procedure, widely reported as about 70% of cases [6, 7, 9] . In our series, this type is also the most frequent, but with only about 50% of cases. The explanation may be found in the increased number of SL in other locations, particularly the left upper SL (LUSL), frequently with associated arterial reconstruction [10, 12, 18, 19] .
Eleven patients underwent an extended SL, an alternative procedure removing more than one lobe, using a previously described bronchoplasty technique to avoid PN in locally advanced lung cancer [20, 21] . The most frequent indication in our series was RUSL plus median lobectomy or 6 segment associated with the upper lobe in both sides. For this operation, a good amount of lung parenchyma is mandatory to prevent pleural space complications and anastomosis failure. These operations require particularly experienced hands in patients with severe respiratory impairment, a second tumour after previous lung resections or poor prognosis due to preoperative clinical conditions [16, 21] .
Without any doubt, the loss of pulmonary function and the rate of major complications are substantially less in regular or extended sleeve lobectomies than in PNs [11, [21] [22] [23] In fact, the deterioration of the lung reserve has been established as 10% and 30% after SL and PN, respectively [9] . Even less deterioration in lung function than expected has been detected in the SL group, likely due to smoking cessation after surgery or lung-reduction volume effect. Other factors also may play a role, such as aggressive postoperative treatment of COPD or overinflation of the preserved lobe(s).
Healing of the anastomosis depends directly on early revascularisation and the vascular support by surrounding tissues and the bronchi itself. Ischaemia and infection lead to anastomotic insufficiency and failure [6, 14] intravenous antibiotics, largely used in lung transplant patients [19] . This aggressive strategy for broncho-angioplastic reconstructions to avoid PN greatly reduced the immediate and long-term mortality rate after major resection. First, the number of PNs decreased greatly and the rate of major complications such as bronchial failure and acute respiratory distress syndrome (ARDS) become almost anecdotal. Second, these reconstructive techniques increased the number of respiratory impaired patients with central tumours who are eligible for surgery, increasing the general resectability rate in NSCLC patients [12] . Finally, surgical treatment of second primary tumours, often precluded for functional reasons, was more frequently salvaged as a treatment option [9] .
Tumour recurrence is well studied in SL and PN. It seems that local control of the disease is similar after both procedures, with a recurrence rate of 20-30%. Without a doubt, the main problem in these patients is systemic recurrence, the most remarkable factor for long-term survival [4, 7, 15, 16, 23] .
Other long series describing the results of SL or comparing SL and PN results have been published (Table 6) [4, 5, 7, 9, 15, 16, 19, [22] [23] [24] [25] . The series frequently lasted for decades, as broncho-angioplastic techniques were developed in these centres. However, very little information was provided concerning the PN:SL ratio. When this concept is analysed, the number of PNs was anomalously high and the SL rate becomes lower than expected. There are three possible explanations: first, the implantation of these techniques took time and these series were retrospectively collected over decades; second, the number of PNs was higher in the 1980s and 1990s due to the enormous delay in lung cancer diagnosis, which was explained by the difficult access to high-definition thoracic images in some countries at the time. Finally, health promotion and health-care networks are significantly better these days than in the past, improving early diagnosis of lung cancer and allowing the avoidance of PNs.
The PN:SL ratio can now be used as a quality standard. An anomalously high number of PN leads to the probability of higher long-term postoperative mortality and to a poor QoL, frequently precluding other postoperative treatments such as chemo-or radiotherapy. In the authors' opinion, the PN:SL ratio should be at least 1:1.5 or 2, promoting these reconstructive surgeries in units with a lower rate. Longterm follow-up seems to make clear the beneficial effects of avoiding PNs [11] . Therefore, increased use of these techniques may be desirable and, despite their complexity, may promote better surgical results. The authors are well aware of the limitations of this study regarding the small number of PN and SL cases. However, we believe that PN should be avoided in any case and in any NSCLC stage because of the positive impact on QoL, long-term survival and respiratory function. Unfortunately, PN will remain the only surgical option for some patients.
